Treatments that reduce suffering and incorporate patient values aren’t common in kidney disease care. That’s changing
Demand for healthy kidneys has long outstripped supply. But better testing and treatment are expanding the donor pool
Minority patients are diagnosed later, stay on dialysis longer and are added to transplant lists less quickly. Why?
Joint ventures between nephrologists and dialysis centers have expanded treatment. Critics ask: At what cost?
A new California law aims to curb what sponsors say is profiteering by dialysis centers. But are there any easy answers?